CBX Therapeutics is a science-first biotech company developing innovative, cannabinoid-based solutions for neurological and neurodegenerative disorders. Our approach is grounded in translational strategy, regulatory insight, and real-world clinical relevance, ensuring that every product we develop delivers clear therapeutic value and follows a defined, feasible path to market.

We operate at the intersection of innovation, disciplined execution, and strategic focus. From first concept to clinical readiness, CBX applies a rigorous development model based on targeted indication selection, biomarker-informed product design, and a lean, milestone-driven execution framework. With active programs addressing neurological conditions primarily Parkinson's disease, we are building a differentiated portfolio supported by robust scientific rationale and early clinical momentum.

CBX has developed a platform for next-generation cannabinoid formulations and applies it across discovery, development, and commercialization of proprietary products combining pharmacological precision with patient-centered outcomes. We welcome collaboration with clinical sites, distribution partners, and wellness brands who share our commitment to scientific integrity and real-world impact.

With R&D operations based in Israel, and a business hub in California, CBX brings together global scientific expertise, regulatory strength, and commercial agility. Our mission is clear: to turn bold therapeutic concepts into trusted, effective products that backed by science, built for patients, and ready for the real world. 

CBX Therapeutics

Org chart

Teams

Offices

CBX Therapeutics

Org chart

Teams

Offices

Related companies